BDBM516582 (2R)-2-(diethylamino)-1- [(2S)-2-(5-{4-[5-(2-{(2S)- 1-[(2R)-2-(diethylamino)- 2-phenylacetyl]pyrrolidin- 2-yl}-1H-imidazol-5-yl)-1- benzofuran-2-yl]phenyl}- 1H-imidazol-2-yl) pyrrolidin-1-yl]-2- phenylethanone::US11053243, Example 193

SMILES CCN(CC)[C@@H](C(=O)N1CCC[C@H]1c1ncc(-c2ccc(-c3cc4cc(-c5cnc([C@@H]6CCCN6C(=O)[C@@H](c6ccccc6)N(CC)CC)[nH]5)ccc4o3)cc2)[nH]1)c1ccccc1

InChI Key InChIKey=DGBILIJUKKPTAN-UHFFFAOYSA-N

Data  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 516582   

TargetGenome polyprotein(HCV)
Merck Sharp & Dohme

US Patent
LigandChemical structure of BindingDB Monomer ID 516582BDBM516582(US11053243, Example 193 | (2R)-2-(diethylamino)-1-...)
Affinity DataEC50:  0.0500nMAssay Description:Measurement of inhibition by compounds was performed using the HCV replicon system. Several different replicons encoding different HCV genotypes or m...More data for this Ligand-Target Pair
In Depth
Date in BDB:
2/13/2022
Entry Details
US Patent